
Husband, Father, Orthopaedic Surgeon @ClevelandClinic, Regenerative Medicine, Tissue Engineering, Stem Cells, Opinions = my own
Joined September 2015
- Tweets150
- Following72
- Followers526
- Likes89
Our team @ClevelandClinic @CCLRI is extraordinary proud that the technology that we translated in forming @x_technologies is being discovered, and demonstrating valuable inthe cell therapy community, and particularly the remarkable team at @AspenNeuro.
prnewswire.com/news-releases…
6
58
George Muschler, MD retweeted
pubmed.ncbi.nlm.nih.gov/3812…
NO utility of requiring PROMs with a minimum follow-up of 2 years for THA and TKA
Research efforts should be focused on registries evaluating implant survivorship at longer-term follow-up, while PROMs should be better assessed up to 1-year follow-up
George Muschler, MD retweeted
The official welcome to ISCT 2023 Paris from our president Jacques Galipeau!
“The wind is in our sails”
#ISCT2023
George Muschler, MD retweeted
#ISCT2023 Presidential Luncheon celebrating contributions of our #celltherapy #genetherapy leaders and successful #Paris Annual Meeting @ISCTglobal
Good interview on the status of new musculoskeletal technologies earlier this week. wakr.net/local-news/this-wee…
1
1
80
I am very proud to be inducted as an @AAASFellowsSocS this year, and grateful for the many collaborators, colleagues and students who have made our work @ClevelandClinic, @LernerResearchInstitute and beyond possible
2
7
109
George Muschler, MD retweeted
I am very proud to be inducted as an @AAASFellowsSocS this year, and grateful for the many collaborators, colleagues and students who have made our work @ClevelandClinic, @LernerResearchInstitute and beyond possible. linkedin.com/posts/geoff-vin…
George Muschler, MD retweeted
THA PROMs Phenotypes predict Dissatisfaction - #AAOS2022 pubmed.ncbi.nlm.nih.gov/3527… #StandWithUkraine️ – at Chicago, IL
George Muschler, MD retweeted
Congratulations to Nicolas Piuzzi, MD the ORS Strategies in Clinical Research Section Podium Award Recipient at #ORS2022!
Learn more about the Section & Join us at the Scientific meeting in April!
ors.org/strategies-clinical-…
George Muschler, MD retweeted
If you think Prior Covid protects against Omicron (B.1.1.529), think again
medrxiv.org/content/10.1101/…
and
"Neutralizing antibody titers against Omicron were low, even below the limit of detection in a significant fraction of convalescent individuals
drive.google.com/file/d/1zjJ…
George Muschler, MD retweeted
Great 1-slide summary. I find the experimental data convincing that Omicron is substantially less able to infect lung cells.
Replying to @EricTopol
5 Studies, 5 Figures. All consistent, independent replications in vivo, in vitro. Omicron can't infect lungs or lung cells as well as prior variants.
@KU_Leuven @SystemsVirology @GuptaR_lab @hkumed @LivUni
George Muschler, MD retweeted
Replying to @WBC24News @BNODesk
George Muschler, MD retweeted
UK had a sharp decoupling between Covid cases and deaths through its recent delta wave, a trend that hopefully continues with omicron. This is a measure of vaccines and population immunity that’s mitigating the most severe impact of new infections, changing how we confront SARS2.
George Muschler, MD retweeted
On his last day as @NIHDirector, we want to #ThankYouDrCollins for his service. As the longest serving appointed Director, he has steered the country’s largest medical research agency with a calm hand, a scientific mind, & a deep commitment to the well-being of all Americans.
George Muschler, MD retweeted
Adding to the body of data for booster shot effectiveness, a new @TheLancet report of over 728,000 people w/ 3 shots vs >728,000 matched controls (2 shots):
93% reduction of Covid hospitalizations
thelancet.com/journals/lance…
George Muschler, MD retweeted
Upcoming ISCT webinar on November 17 on 'Measuring and Managing Batch Variation in MSC Fabrication'
Featuring @MuschlerMd, Pamela Robey, Sowmya Viswanathan, and David Stroncek
Read the details and register: isctglobal.org/events/event-…




























